Strategic Plan: Advancing Comprehensive Biomarker Testing in NSCLC
Multi-stakeholder strategic plan to reduce barriers and achieve universal comprehensive biomarker testing for all eligible NSCLC patients.
Key Activities
Product of the 2020 Summit on Optimizing Lung Cancer Biomarkers in Practice. Multifaceted approach: policy-level advocacy plus development/dissemination of targeted educational materials, clinical decision tools, and guides for patients, physicians, and payers. Serves as a roadmap for many downstream NLCRT resources.